Main Treatment Choices in the 2 First Lines of Therapy for Multiple Myeloma in Patients with High Risk Cytogenetics: Lesson from the Real World in the EU5 Countries and the USA

被引：0
|
作者：
Blin, Nicolas [1 ]
Mai, Christine [2 ]
Ertl, Siegfried [3 ]
Schneider, Elodie [2 ]
Leberre, Marine [2 ]
Yilmaz, Melissa [2 ]
机构：
[1] Nantes Univ Hosp, Dept Hematol, Nantes, France
[2] AplusA, Lyon, France
[3] AplusA, London, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189254
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 44 条
  • [41] Real-world Data on Safety Outcome with Treatment of Adjuvant Abemaciclib plus Endocrine Therapy in High-risk Early Hormone-positive, HER2-negative Breast Cancer Patients
    Neralla, H.
    Herring, K.
    Stevens, A.
    Rea, D.
    Pallan, L.
    [J]. CLINICAL ONCOLOGY, 2024, 36 (04) : E110 - E111
  • [42] Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in the United States : Results from the DELIVER High Risk real-world study
    Sullivan, Sean D.
    Freemantle, Nick
    Gupta, Rishab A.
    Wu, Jasmanda
    Nicholls, Charlie J.
    Westerbacka, Jukka
    Bailey, Timothy S.
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (01)
  • [43] Is There Still a Role for Endocrine Therapy Alone in HR+/HER2-Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies
    Cazzaniga, Marina Elena
    Verusio, Claudio
    Ciccarese, Mariangela
    Fumagalli, Alberto
    Sartori, Donata
    Valerio, Maria Rosaria
    Airoldi, Mario
    Moretti, Gabriella
    Ficorella, Corrado
    Gianni, Lorenzo
    Michelotti, Andrea
    Zambelli, Alberto
    Febbraro, Antonio
    Generali, Daniele
    Pistelli, Mirco
    Garrone, Ornella
    Musolino, Antonino
    Vici, Patrizia
    Maur, Michela
    Mentuccia, Lucia
    La Verde, Nicla
    Bianchi, Giulia Valeria
    Artale, Salvatore
    Blasi, Livio
    De Laurentiis, Michelino
    Atzori, Francesco
    Turletti, Anna
    Porpiglia, Mauro
    Santini, Daniele
    Fabi, Alessandra
    Gebbia, Vittorio
    Schirone, Alessio
    Palumbo, Raffaella
    Ferzi, Antonella
    Frassoldati, Antonio
    Scavelli, Claudio
    Clivio, Luca
    Giordano, Monica
    Donadio, Michela
    Biganzoli, Laura
    Del Mastro, Lucia
    Bisagni, Giancarlo
    Livi, Lorenzo
    Natoli, Clara
    Montemurro, Filippo
    Riccardi, Ferdinando
    Romagnoli, Emanuela
    Marchetti, Paolo
    Torri, Valter
    Pronzato, Paolo
    [J]. BREAST CARE, 2020, 15 (01) : 30 - 37
  • [44] Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy Increases the Feasibility of Long-Term PI Treatment and Benefit for Newly Diagnosed Multiple Myeloma (NDMM) Patients in an Outpatient Setting: Updated Real-World Results from the Community-Based United States (US) MM-6 Study
    Girnius, Saulius K.
    Yimer, Habte A.
    Noga, Stephen J.
    Manda, Sudhir
    Lyons, Roger M.
    Bogard, Kimberly
    Whidden, Presley
    Cherepanov, Dasha
    Lu, Vickie
    Aiello, Jack
    Richter, Joshua R.
    Rifkin, Robert M.
    [J]. BLOOD, 2020, 136
12345